These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2166721

  • 1. Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
    Falkson G, Chasen MR, Falkson HC.
    Invest New Drugs; 1990 May; 8(2):215-9. PubMed ID: 2166721
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK.
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [Abstract] [Full Text] [Related]

  • 4. Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
    Ghosn M, Droz JP, Theodore C, Pico JL, Baume D, Spielmann M, Ostronoff M, Moran A, Salloum E, Kramar A.
    Cancer; 1988 Jul 01; 62(1):24-7. PubMed ID: 3133101
    [Abstract] [Full Text] [Related]

  • 5. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH, Wen XP, Hu L.
    Ai Zheng; 2002 Aug 01; 21(8):907-9. PubMed ID: 12478905
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.
    Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C.
    Cancer Chemother Pharmacol; 1986 Aug 01; 18 Suppl 2():S10-2. PubMed ID: 3102088
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
    Chen YM, Wu MF, Perng RP, Chou CM, Yang KY, Lin WC, Tsai CM, Liu JM, Whang-Peng J.
    Jpn J Clin Oncol; 1997 Apr 01; 27(2):76-9. PubMed ID: 9152794
    [Abstract] [Full Text] [Related]

  • 8. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR.
    Lung Cancer; 1996 Jun 01; 14(2-3):315-29. PubMed ID: 8794413
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Asamoto H, Kawahara M, Iwami F, Kuba M, Furuse K, Tamura T, Saijo N, Shimoyama M.
    Jpn J Clin Oncol; 1998 Dec 01; 28(12):745-8. PubMed ID: 9879292
    [Abstract] [Full Text] [Related]

  • 10. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S.
    Semin Oncol; 1992 Dec 01; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [Abstract] [Full Text] [Related]

  • 11. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E, Paul K.
    Semin Oncol; 1992 Feb 01; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [Abstract] [Full Text] [Related]

  • 12. Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Drings P, Abel U, Bülzebruck H, Stiefel P, Kleckow M, Manke HG.
    Cancer Chemother Pharmacol; 1986 Feb 01; 18 Suppl 2():S34-9. PubMed ID: 3028662
    [Abstract] [Full Text] [Related]

  • 13. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
    Graziano SL, Herndon JE, Richards F, DiFino S, Modeas C, Duggan DB, Green MR.
    Cancer; 1993 Jul 01; 72(1):62-8. PubMed ID: 8389667
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Nobile MT, Rosso R, Brema F, Cinquegrana A, Santi L.
    Tumori; 1984 Oct 31; 70(5):433-7. PubMed ID: 6438851
    [Abstract] [Full Text] [Related]

  • 15. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Wu MF, Perng RP, Chen YM, Liu JM, Yang SL, Whang-Peng J.
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug 31; 60(2):67-73. PubMed ID: 9360330
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
    Crotzer DR, Wolf JK, Gano JB, Gershenson DM, Levenback C.
    Gynecol Oncol; 2007 May 31; 105(2):399-403. PubMed ID: 17292457
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B, Hansen OP, Hansen HH, Hansen M.
    Semin Oncol; 1992 Feb 31; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 31; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.